Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)

We propose to analyze the kinetics of the main marker of inflammation in GCA in order to understand its links with initial clinical manifestations and the possible appearance of complications and/or relapses. Early assessment of the rate of CRP normalization would enable us to adapt the therapeutic strategy in order to avoid complications and/or relapses.

NCT Number	NCT07720804
Lead Sponsor	University Hospital, Limoges
Conditions	Giant Cell Arteritis (GCA)
Enrollment	40 participants
Start Date	2026-06-22
Primary Completion	2029-06-22 (estimated)
Study Completion	2030-06-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-22